Intellectual Property India Publishes Patent Application for 'Inhibitors Of Ripk2 And Medical Uses Thereof' Filed by Odyssey Therapeutics, Inc.

MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202517048635 A) filed by Odyssey Therapeutics, Inc., Boston, on May 20, for 'inhibitors of ripk2 and medical uses thereof.'

Inventor(s) include Vanhuis, Chad; Pan, Shifeng; Koelmel, Dominik, K.; Aversa, Robert; Taylor, Clarke; and Wlodarska, Marta.

The application for the patent was published on June 20, under issue no. 25/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to RIPK2 inhibitors represented by structural formula (I). The disclosure further relates to pharmaceutical composition comprising the RIPK2 inhibitors and methods of treatment of conditions such as inflammatory diseases, a...